April 2017- The National Institutes of Health will be incorporating a new "Human Subjects and Clinical Trial Information form" into the grant and contract application process. Beginning January 25, 2018, every applicant will be required to complete this form whenever human subject research or clinical trials are indicated. To learn more, visit: https://grants.nih.gov/policy/clinical-trials/new-human-subject-clinical-trial-info-form.htm
February 2017- The U.S. Department of Health and Human Services has finalized major revisions to the "Common Rule". These changes go into effect January 19, 2018. The revisions include changes to the definition of human subject research where activities with identifiable biospecimens are involved, changes to the informed consent process, inclusion of a broad consent process for storage and secondary research of identifiable information and biospecimens, new and revised categories of Exempt research, and new categories of research excluded from IRB review altogether. To view the final revisions, visit the HHS web page. The Council on Government Relations (CoGR) has a nicely summarized description of the changes here.
September 2015- The U.S. Department of Health and Human Services has proposed major revisions to the "Common Rule". The Common Rule is the groundwork on which IRB reviews of human subject research is built. The revisions include changes to the definition of human subject research where activities with stored biological specimens are involved, changes to the informed consent process, new and revised categories of Exempt research, and new categories of research excluded from IRB review. To view the proposed revisions and find out how to submit formal comments to DHHS regarding the changes, please visit the announcement on the DHHS web site. To view webinars on each of the major changes to the Common Rule, you can visit OHRP's website here: http://www.hhs.gov/ohrp/education/training/nprmwebinars.html
The mission of the Institutional Review Board (IRB) is to ensure the rights and welfare of people who agree to participate in UAF research projects.
One way that the IRB and Office of Research Integrity (ORI) work to fulfill the IRB mission is by encouraging dialog between researchers and the community on issues related to the responsible and respectful conduct of research. As part of this outreach, ORI co-sponsored Fred Gray's January 2007 visit to UAF as part of our observation of Martin Luther King, Jr. Day and Alaska Civil Liberties Day. Mr. Gray, a noted civil rights attorney, spoke about his personal relationships with and representation of the men enrolled in the Tuskegee Syphilis Study without their informed consent and their families. This case was one of the driving forces behind the development of laws and regulations to protect human participants in research studies in the United States.
An archived webcast of Mr. Gray's January 19, 2007 lecture is available at http://www.alaska.edu/oit/cts/streaming/srchive/2007/IRB/ (requires Flash Player to view). ORI also has several DVDs of the lecture that may be checked out for UAF educational uses. Contact ORI for more information or to request a copy.
IRB Meetings & Deadlines
The UAF IRB meets monthly to discuss applications requiring full board review and to conduct other IRB business. Protocol related applications must be submitted via IRBNet by 5:00 p.m. local time 10 business days prior to the meeting.
Please submit non-protocol related items to the Research Integrity Administrator via e-mail to email@example.com at least 5 business days prior to the scheduled meeting date.
Winter/Spring IRB Meetings:
- Generally the first Wednesday of each month
- Location: 210 WRRB
- Time: 9:00am to 10:00am
- Submission Deadline: Two weeks prior to each meeting date @ 5:00 P.M. (ADT)
Note: All submissions for IRB review must be made through IRBNet!
All researchers with projects to be reviewed by the full board are welcome to attend. Please let us know if you plan to attend at x7800.